Buildkite
Buildkite keeps converting hand-rolled agent workarounds into first-class CI primitives.
A side-by-side editorial comparison of cofad and PowerTOST — release velocity, themes, recent moves, and the top alternatives to consider.
Contrast analysis with a Shiny front end, shipping about one release a year
cofad performs contrast analyses for factorial designs in both between- and within-subject forms, and ships a Shiny GUI alongside the R interface. The 0.3.0 release in 2024 was the substantial one: a helper for calculating differences between two sets of lambdas for competing contrast analysis, improved summary output, removal of the plyr dependency, a rebuilt Shiny interface using standard elements after the sortable drag-and-drop proved unstable, and a change of maintainer to Johannes Titz. The most recent release is a one-line patch fixing degrees of freedom in the t-test table.
A bioequivalence sample-size workhorse whose news is which regulator it now covers
PowerTOST computes power and sample size for bioequivalence and its changelog reads as a record of regulatory divergence more than statistical development. Version 1.5-3 added the Gulf Co-operation Council as a regulator setting; 1.5-4 and 1.5-6 stripped 'FDA' out of the narrow-therapeutic-index function names once China's CDE began requiring the same evaluation. The most recent release, 1.5-7, is a single fix to how nvec() splits a total sample size across sequences.
cofad performs contrast analyses for factorial designs in both between- and within-subject forms, and ships a Shiny GUI alongside the R interface. The 0.3.0 release in 2024 was the substantial one: a helper for calculating differences between two sets of lambdas for competing contrast analysis, improved summary output, removal of the plyr dependency, a rebuilt Shiny interface using standard elements after the sortable drag-and-drop proved unstable, and a change of maintainer to Johannes Titz. The most recent release is a one-line patch fixing degrees of freedom in the t-test table.
Development is slow and correctness-led. The record runs from a JOSS publication in 2021 through a near three-year gap to a release that both extended the method and repaired the GUI, then a degrees-of-freedom fix. Maintainer and author order changed in 0.3.0, which typically marks a handover rather than a burst of new work, and the cadence since is consistent with that.
Expect low-frequency correctness releases; the competing contrast analysis helper added in 0.3.0 is the most likely thing to be extended if anything is.
PowerTOST computes power and sample size for bioequivalence and its changelog reads as a record of regulatory divergence more than statistical development. Version 1.5-3 added the Gulf Co-operation Council as a regulator setting; 1.5-4 and 1.5-6 stripped 'FDA' out of the narrow-therapeutic-index function names once China's CDE began requiring the same evaluation. The most recent release, 1.5-7, is a single fix to how nvec() splits a total sample size across sequences.
The package is in long maintenance with a widening regulatory surface: the statistical methods are settled, and releases arrive when an agency publishes a framework that can be expressed as a settings variant of an existing method. Function naming has been deliberately decoupled from any single agency, with the deprecated FDA-suffixed aliases carried for years before removal. Cadence has slowed to roughly one release every eighteen months.
The next release is most likely another regulator setting or a small fix; on the deprecation notice already given, the power.NTIDFDA()-style aliases are the obvious removal candidate.
Other Infra & APIs products tracked by Sparkpulse, ranked by recent ship velocity. Each card links to a full editorial trajectory and lets you pivot into a head-to-head comparison with either cofad or PowerTOST.
Buildkite keeps converting hand-rolled agent workarounds into first-class CI primitives.
Cursor's agents stop waiting to be asked - they subscribe, and they hold a goal until it's done.
Nexus does the diagnosis; the agent is now reaching into the status page too.
Warp turned its quarter of software-factory essays into infrastructure you can buy.
Okta's developer blog is a Cross App Access campaign, now diluted by advocacy-team storytelling.
A leaf-temperature model that finished its job in 2020 and has stayed finished
See all cofad alternatives → · See all PowerTOST alternatives →
Latest ship moves from both products, interleaved chronologically. ⚡ = editorial spark.
Both compete on the same themes — maintenance — within Infra & APIs. cofad and PowerTOST are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). See the at-a-glance table above for a side-by-side breakdown of velocity, recent sparks, and editorial themes.
Sparkpulse doesn't pick a winner — we score release velocity, not feature parity. cofad and PowerTOST are shipping at a similar cadence (velocity 0.0 vs 0.0, both within Sparkpulse's "active" band). For your specific use case, the alternatives sections above list other Infra & APIs products to evaluate alongside.
Top cofad alternatives in Infra & APIs are ranked by recent ship velocity. Browse the "cofad alternatives" section above for the current picks, or visit /alternatives/cofad for the full list with editorial commentary on each.
Top PowerTOST alternatives in Infra & APIs are ranked by recent ship velocity. Browse the "PowerTOST alternatives" section above for the current picks, or visit /alternatives/powertost for the full list with editorial commentary on each.